As announced in January 2007.

.. The trial, called ORACLE MS will evaluate the safety and efficacy of two doses of cladribine tablets versus placebo in the treatment of patients who had a first clinical event suggestive of MS. Cladribine tablets are currently being studied in a pivotal Phase III trial – the CLARITY study – for the treatment of relapsing forms of MS. As announced in January 2007 , CLARITY was complete the first Phase III pivotal trial among all oral compounds in development for MS application. Cladribine Tablets were fast track designation fast track designation by the U.S. Food and Drug Administration. Our commitment to evidence for the initiation of treatment with a disease-modifying drug in patients a first a first clinical event suggestive of multiple sclerosis, a first stage of the disease when clinical manifestations are not necessarily pronounced but where the potential exists held of irreversible neurological damage, Dr.

For more information,cell,al Malaria is double WHO estimatesAt least 500 million people have malaria, twice as many as the 273 million estimated after WHO, by Bob Snow, who at the Kenyan Medical Research Institute is working, Kenya. Most cases are in Africa south of the Sahara. However, Southeast Asia accounts for one quarter of the total.Advisors to the U.S. Food and Drug Administration review meeting late next month for a new Agency report which for increased warning, better consumer and limits cans both prescription paracetamol and over-the Counter acetaminophen is called, best known like Tylenol.

Thursday U.S. Regulatorsy News) – One month after commissioned stringent warnings about risk of liver damage from analgesics of paracetamol, U.S. Regulators are to consider even more stringent standards.